ENZO BIOCHEM, INC. Long-Term Debt
ENZO BIOCHEM, INC. had Long-Term Debt of $129.00 thousand as of 2025-04-30, per its 10-Q filed 2025-06-16.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2025-06-16
- 2025-04-30: Long-term Debt, Excluding Current Maturities $129.00K.
- 2025-01-31: Long-term Debt, Excluding Current Maturities $146.00K.
- 2024-10-31: Long-term Debt, Excluding Current Maturities $155.00K.
- 2024-07-31: Long-term Debt, Excluding Current Maturities $189.00K.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2025-04-30 | $129.00K 10-Q · filed 2025-06-16 |
| 2025-01-31 | $146.00K 10-Q · filed 2025-03-17 |
| 2024-10-31 | $155.00K 10-Q · filed 2024-12-16 |
| 2024-07-31 | $189.00K 10-Q · filed 2025-06-16 |
| 2024-04-30 | $180.00K 10-Q · filed 2024-06-13 |
| 2024-01-31 | $234.00K 10-Q · filed 2024-03-13 |
| 2023-10-31 | $219.00K 10-Q · filed 2023-12-15 |
| 2023-07-31 | $269.00K 10-K · filed 2024-10-29 |
| 2023-04-30 | $247.00K 10-Q · filed 2023-06-14 |
| 2023-01-31 | $289.00K 10-Q · filed 2023-03-20 |
| 2022-10-31 | $3.99M 10-Q · filed 2022-12-12 |
| 2022-07-31 | $4.08M 10-K · filed 2023-11-03 |
| 2022-04-30 | $4.18M 10-Q · filed 2022-06-09 |
| 2022-01-31 | $4.27M 10-Q · filed 2022-03-14 |
| 2021-10-31 | $4.31M 10-Q · filed 2021-12-15 |
| 2021-07-31 | $4.36M 10-K · filed 2022-10-14 |
| 2021-04-30 | $4.39M 10-Q · filed 2021-06-11 |
| 2021-01-31 | $4.43M 10-Q · filed 2021-03-16 |
| 2020-10-31 | $4.45M 10-Q · filed 2020-12-11 |
| 2020-07-31 | $4.49M 10-K · filed 2021-10-12 |
| 2020-04-30 | $4.51M 10-Q · filed 2020-06-09 |
| 2020-01-31 | $4.14M 10-Q · filed 2020-03-06 |
| 2019-10-31 | $4.17M 10-Q · filed 2019-12-10 |
| 2019-07-31 | $4.18M 10-K · filed 2020-10-19 |
| 2018-07-31 | $2.00K 10-K · filed 2018-10-15 |
| 2017-07-31 | $22.00K 10-K · filed 2017-09-27 |
| 2016-07-31 | $105.00K 10-K · filed 2016-10-13 |
| 2015-07-31 | $363.00K 10-K · filed 2015-10-13 |
| 2014-07-31 | $369.00K 10-K · filed 2014-10-09 |
| 2013-07-31 | $269.00K 10-K · filed 2013-10-15 |